Yinfeng Chen | Medicine | Women Researcher Award

Published on 04/02/202504/02/2025 by Forensic Scientist Awards

Ms. Yinfeng Chen | Medicine | Women Researcher Award

Attending physician | Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Dr. Yinfeng Chen is an attending physician at the Department of Nephrology, Hangzhou TCM Hospital, affiliated with Zhejiang Chinese Medical University. With over a decade of experience in clinical nephropathy, Dr. Chen has become a recognized expert in the field. She has actively contributed to various academic endeavors and plans to further her research at the Clinical Research Institute of China-Japan Friendship Hospital in 2024. Her expertise lies in kidney diseases, and she is dedicated to providing innovative treatments to improve patient outcomes.

Profile🔍

Scopus

Strengths for the Awards

Solid Academic and Professional Background: Yinfeng holds a postgraduate degree in clinical nephropathy from Zhejiang Chinese Medicine University and has 10 years of clinical experience. This provides a solid foundation for her work in the nephrology field.
Research Contributions: She has conducted significant research on chronic kidney disease and its correlation with conditions like stroke, diabetic kidney disease, FSGS, and chronic kidney failure. Her work contributes directly to improving patient outcomes and advancing the field of nephrology.
Clinical Application and Innovation: Her commitment to providing personalized treatment plans based on individual conditions demonstrates a practical approach to her research, enhancing the impact of her findings on real-world patient care.
Active Participation in Academic Activities: She is engaged in further research at the Clinical Research Institute of China-Japan Friendship Hospital, highlighting her dedication to continuous professional development and collaboration.
Published Research: Her research has been published in reputable journals (doi: 10.1080/0886022X.2025.2452219), contributing to the academic discourse in the nephrology field.
Yinfeng Chen has demonstrated considerable strength in her clinical and research endeavors, particularly in the area of nephrology. Her dedication to improving patient care and advancing the understanding of kidney diseases makes her a strong candidate for the “Women Researcher Award.” With further contributions in publications, patents, or leadership roles in academic organizations, her profile could become even more competitive.

Education 📚

Dr. Chen graduated from Zhejiang Chinese Medicine University with a postgraduate degree in clinical nephropathy. She has since accumulated substantial clinical experience, working in the nephrology department for over 10 years. Her academic journey has continuously been complemented by active participation in academic and research activities.

Experience💼

As an attending physician in nephrology, Dr. Yinfeng Chen has developed tailored treatment plans for patients, particularly in chronic kidney disease (CKD) and diabetic kidney disease. Her decade-long clinical experience has been enriched through various collaborations, including her upcoming research at the Clinical Research Institute of China-Japan Friendship Hospital.

Research Interest On Medicine 🔬

Dr. Chen’s research interests primarily focus on kidney diseases, including chronic kidney disease, stroke, diabetic kidney disease, and FSGS (focal segmental glomerulosclerosis). She has been exploring the correlation between chronic kidney disease and stroke, among other critical issues in nephrology, with a commitment to developing innovative therapies for better patient survival and treatment outcomes.

Awards🏆

Dr. Yinfeng Chen has been nominated for the prestigious “Women Researcher Award,” a recognition of her significant contributions to nephrology and medical research. Her dedication to enhancing kidney disease treatments through her research and clinical expertise makes her an ideal candidate for this award.

Publications📖

Dr. Chen has published several studies in prominent journals. One of her recent articles, titled “Correlation Between Chronic Kidney Disease and Stroke,” was published in the International Journal of Nephrology and Renovascular Disease in 2025. The article can be accessed here. Her work is also cited by numerous other research studies.

Conclusion🌱

With a proven track record in clinical nephrology and an unwavering commitment to advancing kidney disease research, Dr. Yinfeng Chen continues to make significant strides in the field. Her upcoming work and future endeavors promise to further improve kidney disease management and treatment.

Guoying Ni | Microbiology | Best Researcher Award

Published on 04/02/202504/02/2025 by Forensic Scientist Awards

Prof. Dr. Guoying Ni | Microbiology | Best Researcher Award

CEO | Zhongao Biomedical Technology (Guangdong) Co., Ltd | Australia

Dr. Guoying Ni is an esteemed researcher specializing in the tumor microenvironment and immunotherapy. With a PhD from Griffith University School of Medicine, Australia, Dr. Ni has dedicated nearly 15 years to groundbreaking research at the University of Wollongong, Griffith University, University of the Sunshine Coast, and Guangdong Pharmaceutical University. Dr. Ni’s research has led to significant advancements, including the application of nanostructured graphene oxide for targeted immunotherapy and the discovery of tumor-inhibiting properties of Caerin peptides from Australian tree frogs.

Profile

Scopus

Strengths for the Awards

Extensive Research Experience – Dr. Ni has been engaged in tumor microenvironment and immunotherapy research for nearly 15 years across multiple institutions in Australia and China.
Innovative Contributions – Key contributions include using nanostructured graphene oxide for IL-10R antibody delivery and discovering the tumor-inhibitory effects of Caerin peptides.
High-Impact Publications – With nearly 60 research papers published in prestigious journals (Q1-ranked, impact factor over 12), Dr. Ni’s work demonstrates strong academic influence.
Funding and Grants – Dr. Ni has secured over 20 million RMB in research funding, showing recognition and support from funding bodies.

Education 🎓

Dr. Ni obtained a PhD from Griffith University School of Medicine, Australia. During this time, extensive research in immunotherapy and molecular biology laid the foundation for Dr. Ni’s expertise in cancer treatment methodologies.

Experience 🌟

Dr. Ni has held pivotal research positions at multiple prestigious institutions, including the University of Wollongong, Griffith University, University of the Sunshine Coast, and Guangdong Pharmaceutical University. Key contributions include developing a novel antibody delivery system using graphene oxide nanoparticles and evaluating anti-IL-10R antibody peptides in vitro and in vivo. Additionally, Dr. Ni has over eight years of experience supervising master’s and PhD students across Australia and China.

Research Interest On Microbiology 📚

Dr. Ni’s research focuses on tumor immunotherapy, nanomedicine, and molecular oncology. Notable areas of interest include:

Graphene oxide as a targeted antibody delivery system
Anti-IL-10R therapy in cancer treatment
Caerin peptides for tumor suppression and immune response activation
Peptide-based immunotherapies for clinical applications

Awards & Honors 🏆

2022-2023: DVCR/A Launch Research Grant/Award, University of the Sunshine Coast, Australia
2016-2017: HDR Merit Research Grant, Griffith University, Australia
2013: GRPRS Scholarship and HDR Scholarship, Griffith University
Visiting Professor: Guangdong Pharmaceutical University, First People’s Hospital of Foshan, Guangdong Province

Publications 📄

Title: Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophages
- Authors: Fu, Q.; Luo, Y.; Li, J.; … Ni, G.; Wang, T.
- Publication Year: 2024
- Citations: 0
Title: Caerin 1.9–Titanium Plates Aid Implant Healing and Inhibit Bacterial Growth in New Zealand Rabbit Mandibles
- Authors: Long, Y.; Duan, X.; Fu, Q.; … Liu, X.; Yang, W.
- Publication Year: 2024
- Citations: 0
Title: Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1
- Authors: Wang, Y.; Zhong, F.; Xiao, F.; … Wang, T.; Zhang, W.
- Publication Year: 2024
- Citations: 1
Title: Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides
- Authors: Fu, Q.; Luo, Y.; Li, J.; … Wang, T.; Ni, G.
- Publication Year: 2024
- Citations: 0
Title: Proteomic analysis of anti-MRSA activity of caerin 1.1/1.9 in a murine skin infection model and their in vitro anti-biofilm effects against Acinetobacter baumannii
- Authors: Zhang, P.; Tang, S.; Fu, Q.; … Chen, G.; Liu, X.
- Publication Year: 2023
- Citations: 2
Title: Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer
- Authors: Liu, X.; Ni, G.; Zhang, P.; … Yuan, S.; Wang, T.
- Publication Year: 2023
- Citations: 10
Title: Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria
- Authors: Cavallazzi Sebold, B.; Li, J.; Ni, G.; … Liu, X.; Wang, T.
- Publication Year: 2023
- Citations: 6
Title: Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts
- Authors: He, T.; Du, J.; Zhu, K.; … Zhang, P.; Yuan, J.
- Publication Year: 2023
- Citations: 2
Title: Degradation of differently processed Mg-based implants leads to distinct foreign body reactions (FBRs) through dissimilar signaling pathways
- Authors: Liu, X.; Chen, G.; Zhong, X.; … Gao, M.; Li, H.
- Publication Year: 2023
- Citations: 5
Title: PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?

Authors: Cavallazzi Sebold, B.; Ni, G.; Li, J.; … Liu, X.; Wang, T.
Publication Year: 2023
Citations: 3

Conclusion 🎉

Dr. Guoying Ni is a trailblazer in tumor immunotherapy and nanomedicine. With numerous research contributions, multiple prestigious awards, and collaborations with globally recognized scientists, Dr. Ni continues to push the boundaries of medical research to develop innovative cancer treatments. Through dedication and expertise, Dr. Ni’s work is making a significant impact on the future of cancer immunotherapy.

Yuan Zhang | Biology | Best Researcher Award

Published on 04/02/202504/02/2025 by Forensic Scientist Awards

Prof. Yuan Zhang | Biology | Best Researcher Award

Director of kinesiology department | Nanjing Sport Institute | China

Yuan Zhang is a distinguished professor and the Director of the Kinesiology Department at the School of Sports and Health, Nanjing Sport Institute, China. He has dedicated his career to advancing research in exercise interventions for chronic diseases and mitochondrial regulation. With extensive academic and research experience, Professor Zhang has significantly contributed to the fields of sports science and health.

Profile

Scopus

Strengths for the Awards

Extensive Research Contributions – Yuan Zhang has an impressive record of over 30 publications, including studies in high-impact journals such as Oxidative Medicine and Cellular Longevity, Biochemical and Biophysical Research Communications, and Free Radical Biology & Medicine.
Significant Research Impact – His work on exercise interventions in chronic diseases, mitochondrial regulation, and metabolic health has contributed to advancing knowledge in sports science, kinesiology, and health.
International Collaboration – Zhang has conducted research abroad at York University in Canada, showing strong global research engagement.
Leadership and Academic Recognition – Currently serving as a Professor and Director at the Nanjing Sport Institute, demonstrating recognition as a leading expert in his field.
Funding and Grants – He has successfully secured multiple research grants from prestigious sources such as the National Natural Science Foundation of China, reflecting strong research credibility.

Education 🎓

Professor Zhang pursued his Bachelor of Education at Dalian University (2002-2006), followed by a Master of Education at East China Normal University (2006-2009). He further obtained his Doctor of Education from the same institution (2009-2013). Additionally, he undertook a joint doctoral program at York University, Canada, from 2010 to 2012, gaining international exposure to advanced research in kinesiology and health sciences.

Professional Experience 💼

Professor Zhang has a robust academic career. He started as an instructor at the Nanjing Sport Institute (2013-2018), later serving as a postdoctoral researcher at Shanghai Jiaotong University (2018-2022). He was promoted to Associate Professor at Nanjing Sport Institute (2018-2023) and currently holds the position of Professor (since 2023), contributing to teaching, research, and departmental leadership.

Research Interests On Biology 🔬

Professor Zhang specializes in exercise interventions for chronic diseases and mitochondrial regulation. His work focuses on understanding how physical activity influences cellular mechanisms, particularly in metabolic disorders such as diabetes and non-alcoholic fatty liver disease (NAFLD). His research aims to develop effective exercise-based strategies for health improvement.

Awards and Recognitions 🏆

Professor Zhang has received several prestigious awards, including:

First Prize (2021): School-level teaching achievement award, Jiangsu, China.
Third Prize (2021): School-level teaching achievement award, Jiangsu, China.
Second Prize (2020): Third Teaching Competition for Young Teachers, Jiangsu Province.
Second Prize (2018): School-level teaching achievement award, Jiangsu, China.
Second Prize (2017): Micro-course teaching contest in colleges and universities of Jiangsu Province.

Publications 📖

Xiang, M. et al. (2024)
- Title: Effects of exercise, metformin, and combination treatments on type 2 diabetic mellitus-induced muscle atrophy in db/db mice: Crosstalk between autophagy and the proteasome
- Journal: Journal of Physiology and Biochemistry
- Citations: 5
Yuan, X.-M. et al. (2024)
- Title: Beneficial Effects of High-Intensity Interval Training and Dietary Changes Intervention on Hepatic Fat Accumulation in HFD-Induced Obese Rats
- Journal: Physiological Research
- Citations: 0
Lu, J. et al. (2023)
- Title: High-intensity interval training alleviates exhaustive exercise-induced HSP70-assisted selective autophagy in skeletal muscle
- Journal: The Journal of Physiological Sciences
- Citations: 1
Liu, Y. et al. (2023)
- Title: Changes of endoplasmic reticulum stress level in skeletal muscle during recovery acute exhaustive exercise
- Journal: Chinese Journal of Rehabilitation Medicine
- Citations: 0
Liu, J. et al. (2023)
- Title: The combination of exercise and metformin inhibits TGF-β1/Smad pathway to attenuate myocardial fibrosis in db/db mice by reducing NF-κB–mediated inflammatory response
- Journal: Biomedicine and Pharmacotherapy
- Citations: 15
Zhang, Y. et al. (2022)
- Title: Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice
- Journal: Oxidative Medicine and Cellular Longevity
- Citations: 18
Zhang, Y. et al. (2022)
- Title: Effects of different exercise on liver lipid accumulation and FGF21 secretion in obese rats
- Journal: Chinese Journal of Applied Physiology
- Citations: 1
Lu, J. et al. (2021)
- Title: Morphological and functional characterization of diabetic cardiomyopathy in db/db mice following exercise, metformin alone, or combination treatments
- Journal: Biochemical and Biophysical Research Communications
- Citations: 9
Zhang, Y. et al. (2020)
- Title: The intersection of exercise and aging on mitochondrial protein quality control
- Journal: Experimental Gerontology
- Citations: 29
Zhang, Y. et al. (2016)

Title: Absence of Bax and Bak: Implications for Autophagy and Alternative Mitochondrial Functions
Book: Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging Volume 9: Human Diseases and Autophagosome
Citations: 0

Conclusion 🔍

Professor Yuan Zhang is a dedicated academician and researcher with profound contributions to exercise science. His work in chronic disease intervention and mitochondrial regulation has paved the way for innovative health strategies. Through his commitment to research, teaching, and mentorship, he continues to inspire the next generation of scholars in the field of kinesiology and sports health sciences.

Marta Wojcik | Medicine | Best Researcher Award

Published on 01/02/202501/02/2025 by Forensic Scientist Awards

Assoc. Prof. Dr. Marta Wojcik | Medicine | Best Researcher Award

Head of Veterinary Oncology lab | University of Live Sciences in Lublin | Poland

Dr. Marta Wójcik is the Head of the Veterinary Oncology Laboratory at the Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Poland. With a distinguished career in veterinary pathology, her research primarily focuses on liver diseases, especially the mechanisms leading to primary malignant tumors such as hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCA). Her work encompasses both experimental models and in vitro analyses, contributing significantly to the understanding of hepatocarcinogenesis.

Profile

Orcid

Scopus

Strengths for the Awards

Extensive Research Contributions:
- Dr. Wójcik has a well-established research background, primarily focusing on veterinary oncology and liver diseases.
- Her work in hepatocarcinogenesis, fibrosis, and liver disease mechanisms has both veterinary and human medicine implications.
- Multiple research projects, including leading and participating in grants funded by the National Science Centre in Poland and the Polish Ministry of Science and Higher Education.
International Scientific Collaborations:
- Ongoing collaboration with the National Research Council in Pisa, Italy on liver cancer and hepatocytes research.
- Erasmus-funded research and teaching exchanges in Germany, Italy, and Hungary, demonstrating strong international networking.
Publication Record & Reviewer Role:
- Publications in high-impact factor journals, indicating significant contributions to veterinary and medical research.
- Peer reviewer for reputed journals, including Molecules, The American Journal of the Medicine Sciences, and Oncology Letters.
Academic Leadership & Teaching:
- Head of the Veterinary Oncology Lab, indicating leadership in her field.
- Supervisor of PhD students and mentor for undergraduate students in veterinary medicine.
- Teaches advanced courses in Pathophysiology, Oncology, and Laboratory Animal Diseases, which strengthens her role in academia.

Education 🎓

Dr. Wójcik earned her Doctor of Veterinary Medicine (DVM) degree in 1996 from the Agricultural Academy in Lublin. She pursued her Ph.D. at the University of Life Sciences in Lublin, completing it in 2005 with a dissertation titled “Changes in the secretion of Ubiquinone Q10 and secretory parameters of bile in the course of experimental hepatic oxidative stress in sheep.” In 2019, she achieved habilitation with a thesis on the activity of oval stem cells and macrophages in primary hepatic cancer in humans and rats.

Experience 🏢

Beginning her career as a research fellow at the Department of Pathophysiology, University of Life Sciences in Lublin, from 1996 to 2005, Dr. Wójcik then served as an Assistant Professor at the Faculty of Veterinary Medicine until 2019. Since 2020, she has been an Associate Professor, leading the Veterinary Oncology Laboratory. Her international experience includes scholarships and teaching engagements in Germany, Italy, and Hungary, enhancing her global perspective in veterinary medicine.

Research Interests On Medicine 🔬

Dr. Wójcik’s research delves into the pathomechanisms of liver diseases, with a particular emphasis on cancer processes leading to primary malignant tumors. She utilizes experimental rat models and in vitro analyses to study hepatocarcinogenesis. Her recent work focuses on the influence of “trained” M1 macrophages on isolated neoplastic cells and the impact of nutraceuticals on HCC development.

Awards and Recognitions 🏆

Throughout her career, Dr. Wójcik has been recognized for her contributions to veterinary pathology and hepatology. She has secured funding from prestigious institutions, including the National Science Centre in Poland and the Polish Ministry of Science and Higher Education, to support her groundbreaking research projects.

Publications 📚

A Moderate Intake of Beer Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a High-Fat Diet (HFD)-Induced Mouse Model
- Authors: Vornoli, A., Souid, A., Lazzari, B., Capra, E., Pozzo, L.
- Publication Year: 2024
- Citations: 0
Liver Antioxidant Capacity and Steatosis in Laying Hens Exposed to Various Quantities of Lupin (Lupinus angustifolius) Seeds in the Diet
- Authors: Wójcik, M., Grabowski, S., Jarosz, Ł.S., Gruszczyński, K., Marek, A.
- Publication Year: 2024
- Citations: 1
Growth Rate and Bone Hydroxyproline Concentration in Turkeys Fed with a Silage-Composed Diet Modified with Different Diet Cation–Anion Differences (Dcads)
- Authors: Wójcik, M., Stachal, K., Burzec, M., Gruszczyński, K., Korga-Plewko, A.
- Publication Year: 2022
- Citations: 0
Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
- Authors: Korga-Plewko, A., Michalczyk, M., Adamczuk, G., Wójcik, M., Dudka, J.
- Publication Year: 2020
- Citations: 22
Relationship Between Mammary Blood Flow, Infrared Thermography and Ovine Placental Lactogen During the Periparturient Period in Ewes
- Authors: Bobowiec, R., Wójcik, M., Milczak, A., Gregula-Kania, M., Tatarczak, J.
- Publication Year: 2019
- Citations: 1
Influence of Proinflammatory Macrophages (M-1) on Proliferative Activity and PPAR Expression in Neoplastic Rat Hepatocytes In Vitro
- Authors: Wójcik, M., Kosior-Korzecka, U., Plewik, M., Bobowiec, R.
- Publication Year: 2019
- Citations: 0
Changes in Growth Hormone Secretion and Leptin Receptor mRNA Expression Under the Influence of Leptin and Adrenocorticotropin in Pituitary Cells of Early Weaned Ewe Lambs
- Authors: Kosior-Korzecka, U., Wójcik, M., Longo, V., Patkowski, K., Gregula-Kania, M.
- Publication Year: 2019
- Citations: 5
Expression of Receptor Interacting Protein 1 and Receptor Interacting Protein 3 Oval Cells in a Rat Model of Hepatocarcinogenesis
- Authors: Wójcik, M., Bobowiec, R., Lisiecka, U., Śmiech, A.
- Publication Year: 2018
- Citations: 3
Growth Rate and Acid-Base Balance in Turkeys Fed a Silage-Containing Diet Modified by Different Dietary Cation-Anion Difference
- Authors: Gruszczyński, K., Strobel, W., Wójcik, M., Wessely-Szponder, J., Bobowiec, R.
- Publication Year: 2017
- Citations: 1
In Vitro Proinflammatory Polarization of Macrophages Isolated from Hepatocarcinogenic Stage in Humans and Rats
- Authors: Wójcik, M., Wessely-Szponder, J., Cichoz-Lach, H., Celiński, K., Bobowiec, R.
- Publication Year: 2016
- Citations: 4

Conclusion 🔚

Dr. Marta Wójcik’s extensive education, diverse experience, and dedicated research have established her as a leading figure in veterinary pathology, particularly in the study of liver diseases and cancer processes. Her ongoing contributions continue to advance the understanding of hepatocarcinogenesis, benefiting both the scientific community and veterinary medicine.

Xiaogang Song | Computer Science | Best Researcher Award

Published on 29/01/202529/01/2025 by Forensic Scientist Awards

Prof. Xiaogang Song | Computer Science | Best Researcher Award

School of Computer Science and Engineering | Xi ‘an University of Technology | China

Dr. Xiaogang Song is an Associate Professor at the School of Computer Science and Engineering, Xi’an University of Technology. He earned his Ph.D. from Northwestern Polytechnical University and is a member of IEEE. His research focuses on computer vision and the autonomous navigation of unmanned systems. Throughout his career, Dr. Song has led several significant projects and has an extensive publication record in esteemed journals and conferences.

Profile

Scopus

Orcid

Strengths for the Awards

Strong Academic Background – Dr. Xiaogang Song holds a Ph.D. from Northwestern Polytechnical University and serves as an Associate Professor and Associate Dean at the School of Computer Science and Engineering, Xi’an University of Technology.
Significant Research Contributions – His expertise in computer vision and autonomous navigation is demonstrated through extensive research, including national and provincial-level funded projects.
Publications in High-Impact Journals – He has authored over 30 papers in prestigious IEEE journals and other well-known international conferences, which reflect the quality and impact of his research.
Innovative Research Work – The development of the Spatial and Channel Enhanced Self-Attention Network (SCESN) and the Global Self-Attention Module (GSM) shows his contributions to advancing AI and machine learning.

Education 🎓

Dr. Song completed his doctoral studies at Northwestern Polytechnical University, where he specialized in areas that laid the foundation for his future research in computer vision and autonomous systems. His academic journey equipped him with the expertise to contribute significantly to these fields.

Experience 🏫

Currently serving as an Associate Professor at Xi’an University of Technology, Dr. Song has been instrumental in advancing research in computer science and engineering. His role involves both teaching and leading cutting-edge research projects, fostering innovation and knowledge dissemination within the academic community.

Research Interests On Computer Science🔍

Dr. Song’s research interests encompass:

Machine Learning
Multimodal Learning
Computer Vision

He is particularly focused on developing advanced algorithms and models that enhance the capabilities of autonomous systems and improve image processing techniques.

Awards 🏆

Dr. Song has been recognized for his contributions to the field, including:

Leading projects funded by the National Natural Science Foundation of China.
Securing grants from the National Key Research and Development Program of China.
Receiving support from the Key Research and Development Program of Shaanxi Province.

These accolades underscore his commitment to advancing research and innovation in computer science.

Publications 📚

“Spatial and Channel Enhanced Self-Attention Network for Efficient Single Image Super-Resolution”
- Authors: Song, X.; Tan, Y.; Pang, X.; Lu, X.; Hei, X.
- Publication Year: 2025
- Citations: 0
“Single Image Super-Resolution with Lightweight Multi-Scale Dilated Attention Network”
- Authors: Song, X.; Pang, X.; Zhang, L.; Lu, X.; Hei, X.
- Publication Year: 2025
- Citations: 0
“Local Motion Feature Extraction and Spatiotemporal Attention Mechanism for Action Recognition”
- Authors: Song, X.; Zhang, D.; Liang, L.; He, M.; Hei, X.
- Publication Year: 2024
- Citations: 0
“Salient Object Detection With Dual-Branch Stepwise Feature Fusion and Edge Refinement”
- Authors: Song, X.; Guo, F.; Zhang, L.; Lu, X.; Hei, X.
- Publication Year: 2024
- Citations: 4
“TransBoNet: Learning Camera Localization with Transformer Bottleneck and Attention”
- Authors: Song, X.; Li, H.; Liang, L.; Lu, X.; Hei, X.
- Publication Year: 2024
- Citations: 5
“A Universal Multi-View Guided Network for Salient Object and Camouflaged Object Detection”
- Authors: Song, X.; Zhang, P.; Lu, X.; Hei, X.; Liu, R.
- Publication Year: 2024
- Citations: 0
“Self-Supervised Monocular Depth Estimation Method for Joint Semantic Segmentation”
- Authors: Song, X.; Hu, H.; Ning, J.; Lu, X.; Hei, X.
- Publication Year: 2024
- Citations: 0
“PSNS-SSD: Pixel-Level Suppressed Nonsalient Semantic and Multicoupled Channel Enhancement Attention for 3D Object Detection”
- Authors: Song, X.; Zhou, Z.; Zhang, L.; Lu, X.; Hei, X.
- Publication Year: 2024
- Citations: 1
“Unsupervised Monocular Estimation of Depth and Visual Odometry Using Attention and Depth-Pose Consistency Loss”
- Authors: Song, X.; Hu, H.; Liang, L.; Lu, X.; Hei, X.
- Publication Year: 2024
- Citations: 4
“Image Super-Resolution with Multi-Scale Fractal Residual Attention Network”

Authors: Song, X.; Liu, W.; Liang, L.; Lu, X.; Hei, X.
Publication Year: 2023
Citations: 5

Conclusion 📝

Dr. Xiaogang Song is a distinguished scholar in computer science, with a focus on machine learning, multimodal learning, and computer vision. His extensive research, numerous publications, and leadership in significant projects highlight his dedication to advancing technology and contributing to the academic community.

Chia-Chi Key | Molecular Biology | Best Researcher Award

Published on 27/01/202527/01/2025 by Forensic Scientist Awards

Dr. Chia-Chi Key | Molecular Biology | Best Researcher Award

Department of Internal Medicine | Wake Forest University School of Medicine | United States

Dr. Chia-Chi Chuang Key, Ph.D., is an accomplished Assistant Professor in the Department of Internal Medicine at the Wake Forest University School of Medicine. With a focus on Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Dr. Key has contributed significantly to translational research and metabolic science, paving the way for innovative treatments in lipid metabolism and obesity-related disorders.

Profile

Google Scholar

Scopus

Orcid

Strengths for the Awards

Academic Background and Career Progression:
Dr. Key holds a Ph.D. in Nutrition, coupled with postdoctoral training in lipid sciences at Wake Forest University School of Medicine. Her career trajectory includes roles such as instructor, tenure-track assistant professor, and a research-track assistant professor, demonstrating sustained academic growth.
Research Contributions:
Dr. Key’s work focuses on crucial topics such as lipid metabolism, inflammation, and diabetes, with significant findings published in high-impact journals (e.g., Journal of Lipid Research, American Journal of Clinical Nutrition). Her research has practical implications for understanding metabolic disorders and improving public health.
Funding and Grants:
She has secured competitive research grants, including a Department of Defense (DOD) grant on CRISPR-based adipose therapeutics and an NIH SPLENDOR-NC Pilot Grant. Her involvement as a co-investigator in R01 studies highlights her collaborative research efforts.
Recognition and Awards:
Dr. Key’s accolades, such as the Research Excellence Award (2020, 2021), Translational Research Academy Scholar (2022), and SPLENDOR-NC Scholar (2023), reflect her contributions and recognition within her field.

Education 🎓

Dr. Key began her academic journey at Taipei Medical University, where she earned a Bachelor of Science in Medical Technology (2003). She then obtained a Master’s degree in Toxicology from the National Taiwan University College of Medicine (2005). She furthered her education with a Ph.D. in Nutrition from the University of North Carolina at Greensboro (2012), where her dissertation focused on the anti-inflammatory effects of grape polyphenols on human adipocytes and obese mice.

Experience 💼

Dr. Key’s professional journey includes roles as a Research Technician at the National Taiwan University and a Graduate Assistant at UNC Greensboro. She later joined Wake Forest University School of Medicine, transitioning from Instructor to Assistant Professor, contributing to both molecular medicine and translational science. She also served as Core Director of the Metabolic Phenotyping Shared Resource (2021–2024), showcasing her leadership and expertise in metabolic research.

Research Interests On Molecular Biology 🔬

Dr. Key’s research is centered on lipid metabolism, obesity-related diseases, and translational approaches to improving metabolic health. Her investigations delve into the mechanisms of lipid transport and the role of adipose tissue in metabolic disorders, exploring therapeutic potentials in Type 2 Diabetes and obesity.

Awards 🏆

Dr. Key’s excellence has been recognized through numerous awards, including the Graduate Student of the Year Award (2012), the Research Excellence Award from Wake Forest University School of Medicine (2020, 2021), and her recognition as a Translational Research Academy Scholar (2022). Her work has also earned her travel stipends and acknowledgment for outstanding scientific publications.

Publications 📚

Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications
- Authors: A. Kennedy, K. Martinez, C.C. Chuang, K. LaPoint, M. McIntosh
- Year: 2009
- Citations: 651
An abundant dysfunctional apolipoprotein A1 in human atheroma
- Authors: Y. Huang, J.A. DiDonato, B.S. Levison, D. Schmitt, L. Li, Y. Wu, J. Buffa, T. Kim, …
- Year: 2014
- Citations: 422
Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases
- Authors: C.C. Chuang, M.K. McIntosh
- Year: 2011
- Citations: 291
Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-α–mediated inflammation and insulin resistance in primary human adipocytes
- Authors: C.C. Chuang, K. Martinez, G. Xie, A. Kennedy, A. Bumrungpert, A. Overman, …
- Year: 2010
- Citations: 279
A polyphenol-rich fraction obtained from table grapes decreases adiposity, insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-fed mice
- Authors: B. Collins, J. Hoffman, K. Martinez, M. Grace, M.A. Lila, C. Cockrell, …
- Year: 2016
- Citations: 133
Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and …
- Authors: C.C. Chuang, R.S. Yang, K.S. Tsai, F.M. Ho, S.H. Liu
- Year: 2007
- Citations: 115
Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media
- Authors: A. Bumrungpert, R.W. Kalpravidh, C.C. Chuang, A. Overman, K. Martinez, …
- Year: 2010
- Citations: 113
Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease
- Authors: J. Ding, L.M. Reynolds, T. Zeller, C. Müller, K. Lohman, B.J. Nicklas, …
- Year: 2015
- Citations: 109
Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota in butter fat-fed mice
- Authors: J. Baldwin, B. Collins, P.G. Wolf, K. Martinez, W. Shen, C.C. Chuang, W. Zhong, …
- Year: 2016
- Citations: 107
Conjugated linoleic acid reduces adiposity and increases markers of browning and inflammation in white adipose tissue of mice [S]
- Authors: W. Shen, C.C. Chuang, K. Martinez, T. Reid, J.M. Brown, L. Xi, L. Hixson, …
- Year: 2013
- Citations: 106

Conclusion

Dr. Chia-Chi Chuang Key exemplifies a commitment to advancing scientific knowledge and clinical applications in metabolic health. Through her leadership, research, and teaching, she continues to inspire progress in understanding and treating complex metabolic disorders.

Dongmei Li | Genetics | Best Researcher Award

Published on 23/01/202523/01/2025 by Forensic Scientist Awards

Prof. Dongmei Li | Genetics | Best Researcher Award

Professor | University of Rochester | United States

Dr. Dongmei Li is a distinguished professor at the University of Rochester School of Medicine & Dentistry, where she is actively involved in clinical and translational research. She also holds affiliations with the Goergen Institute for Data Science. With expertise spanning biostatistics, public health sciences, and data science, Dr. Li has made significant contributions to advancing health research through statistical modeling and innovative data analysis methods.

Profile

Scopus

Orcid

Strengths for the Awards

Academic and Professional Excellence:
- Dr. Li holds a Ph.D. in Biostatistics and advanced training in biomedical data science, genetics, and public health, making her expertise highly interdisciplinary.
- Current roles as Professor and Program Director at the University of Rochester underscore her leadership in academia.
Diverse Research Contributions:
- Dr. Li’s research spans clinical and translational sciences, public health, and biostatistics.
- Extensive mentorship for students and postdocs, with multiple mentees achieving national recognition.
Recognition and Honors:
- Recipient of numerous awards, such as the David P. Byar Young Investigator Travel Award and mentorship-related accolades for students.
- Multiple travel grants and special merit awards signify her influence in the research community

Education 🎓

Dr. Li’s academic journey began with a BS in Pomology from Laiyang Agricultural College in China, followed by an MS in Biophysics from China Agricultural University. She later pursued advanced training in the United States, earning an MS in Statistics and a PhD in Biostatistics from The Ohio State University. Her academic pursuits reflect a deep commitment to integrating quantitative methods into biological and health research.

Experience 🏫

Dr. Li’s professional career includes faculty appointments at the University of Hawaii at Manoa, where she developed and taught biostatistics courses, and her current role at the University of Rochester. Over the years, she has advanced from assistant to professor, conducting groundbreaking research in statistical methods for health data and mentoring students and early-career researchers.

Research Interests On Genetics 🔍

Dr. Li’s research focuses on applying statistical models to complex health data, including biomarker discovery, tobacco research, and diabetes studies. She is particularly interested in integrating machine learning with traditional biostatistics to address challenges in health disparities and population health. Her interdisciplinary approach bridges the gap between health sciences and computational methods.

Awards 🏆

Dr. Li has been recognized for her contributions to research and mentoring, receiving accolades such as the David P. Byar Young Investigator Travel Award and the National Student Employee of the Year Award for her mentees. Her numerous scholarships and travel awards highlight her dedication to fostering collaborative research and innovation.

Publications 📚

“Assessing associations between individual-level social determinants of health and COVID-19 hospitalizations: Investigating racial/ethnic disparities among people living with human immunodeficiency virus (HIV) in the U.S. National COVID Cohort Collaborative (N3C)”
- Authors: Dimple Vaidya, Kenneth J. Wilkins, Eric Hurwitz, Jessica Y. Islam, Dongmei Li, Jing Sun, Sandra E. Safo, Jennifer M. Ross, Shukri Hassan, Elaine Hill, et al.
- Publication Year: 2024
- Citations: As of now, this publication has not been cited by other works.
“Public Perceptions of Very Low Nicotine Content on Twitter: Observational Study”
- Authors: Zidian Xie, Xinyi Liu, Xubin Lou, Dongmei Li
- Publication Year: 2024
- Citations: This study has been cited by the following publications:
  - Tracy T. Smith, Richard J. O’Connor, K. Michael Cummings, Alex C. Liber, “Tobacco Control Strategies,” International Encyclopedia of Public Health, 2025.
  - Kiana L. Fall, Robin M. Forbes-Lorman, “No effect on behavior in a pilot study investigating the role of progesterone in nicotine withdrawal in female rats,” BIOS, 2024.
  - Piyush Anand, Vrinda Kadiyali, “Frontiers: Smoke and Mirrors: Impact of E-cigarette Taxes on Underage Social Media Posting,” Marketing Science, 2024.
  - Onyema Greg Chido-Amajuoyi, Dale S. Mantey, Efehi Igbinomwanhia, Onyinye Omega-Njemnobi, Henry Onyeaka, Robert K. Yu, Israel Agaku, Sanjay Shete, “Perceptions of the Addictiveness of Low-Nicotine Cigarettes Versus Typical Cigarettes and Exposure to Tobacco Industry-Sponsored Corrective Campaign,” Substance Use & Misuse, 2024.
  - Carlos Blanco, Benjamin Apelberg, Brian A. King, Wilson M. Compton, “Opportunities for advancing science to inform tobacco regulation in an evolving tobacco landscape,” Molecular Psychiatry, 2024.
“Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic”
- Authors: Lisette Alcantara Sanchez, Eloy Alvarez Guerra, Dongmei Li, Samantha M. King, Shannon P. Hilchey, Qian Zhou, Stephen Dewhurst, Kevin Fiscella, Martin S. Zand
- Publication Year: 2024
- Citations: This publication has not been cited by other works to date.
“Marker gene fishing for single-cell data with complex heterogeneity”
- Authors: Yiren Shao, Qi Gao, Liuyang Wang, Dongmei Li, Andrew B. Nixon, Cliburn Chan, Qi-Jing Li, Jichun Xie
- Publication Year: 2024
- Citations: Currently, there are no citations for this preprint.
“Associations of County-Level Social Determinants of Health with COVID-19 Related Hospitalization Among People with HIV: A Retrospective Analysis of the U.S. National COVID Cohort Collaborative (N3C)”
- Authors: Jessica Y. Islam, Eric Hurwitz, Dongmei Li, Marlene Camacho-Rivera, Jing Sun, Sandra Safo, Jennifer M. Ross, Kenneth Wilkins, Shukri Hassan, Elaine L. Hill, et al.
- Publication Year: 2024
- Citations: This article has not been cited by other publications yet.
“Discussion of Heated Tobacco Products on Twitter Following IQOS’s Modified-Risk Tobacco Product Authorization and US Import Ban: Content Analysis”
- Authors: Minji Kim, Julia Vassey, Dongmei Li, Artur Galimov, Eileen Han, Matthew G. Kirkpatrick, Cassandra A. Stanton, Jenny E. Ozga, Sarah Lee, Jennifer B. Unger
- Publication Year: 2024
- Citations: No citations have been recorded for this study so far.
“Temporal and Thematic Analysis of Promotional Waterpipe-Related Posts on Twitter/X in the US”
- Authors: Puhua Ye, Mengwei Wu, Yiwei Han, Yuka Shimazaki, Jennifer Cornacchione Ross, Erin L. Sutfin, Dongmei Li, Zidian Xie
- Publication Year: 2024
- Citations: This preprint has not been cited by other works.
“Public Perception of the Tobacco 21 Amendment on Twitter in the United States: Observational Study”
- Authors: Liane M. Schneller-Najm, Zidian Xie, Jiarui Chen, Sarah Lee, Emily Xu, Dongmei Li
- Publication Year: 2024
- Citations: There are no citations for this study at this time.
“Public Perceptions of the Food and Drug Administration’s Regulatory Authority Over Synthetic Nicotine on Twitter: Observational Study”
- Authors: Jonathan Zou, Juan Ramon Feliciano, Zidian Xie, Dongmei Li
- Publication Year: 2024
- Citations: This publication has not been cited by other works to date.

Conclusion 🌟

Dr. Dongmei Li’s extensive expertise, innovative research, and dedication to mentoring make her a valuable asset to the academic and scientific community. Her work continues to impact the fields of biostatistics and public health, fostering collaboration across disciplines and inspiring the next generation of researchers.

Fusheng Liu | Biology | Best Researcher Award

Published on 22/01/202522/01/2025 by Forensic Scientist Awards

Dr. Fusheng Liu | Biology | Best Researcher Award

Assistant professor | Xi’an Jiaotong University | China

🌟 Dr. Fusheng Liu is an Assistant Professor at Xi’an Jiaotong University, China. With a rich academic background spanning over a decade, his expertise lies in biomechanics, particularly in the theory and numerical computation of multi-physical field coupling and the mechanical behavior of composite materials. His groundbreaking research has significantly contributed to understanding myocardial fibrosis and pain sensation mechanics.

Profile

Scopus

Orcid

Strengths for the Awards

1️⃣ Academic Excellence:
Dr. Liu holds a robust academic foundation with a PhD, MA, and BA from Xi’an Jiaotong University, where his studies focused on advanced mechanics, solid mechanics, and structural analysis. His doctoral research, titled “Theoretical Investigation into the Coupling Behaviour of Mechanoelectrical Tissue in Myocardial Fibrosis”, has paved the way for deeper insights into cardiac tissue dynamics.

2️⃣ Research Contributions:

Published seven high-quality journal articles in esteemed publications such as the International Journal of Molecular Sciences, Biophysical Journal, and Scientific Reports. These works reflect his expertise in modeling biomechanical processes and cellular interactions.
His research on fibroblast-cardiomyocyte interactions and myocardial fibrosis provides critical insights for medical science and targeted therapies.

3️⃣ Industry Collaboration and Innovation:
Dr. Liu successfully partnered with Siemens to develop a market-ready facial beauty device, showcasing his ability to translate theoretical knowledge into practical applications.

4️⃣ Recognition and Citations:
With 125 citations on ResearchGate, his work has demonstrated tangible academic impact and recognition within the research community.

5️⃣ Research Focus:
Dr. Liu’s exploration of multi-physical field coupling, mechanical behavior of composite materials, and experimental mechanics places him at the forefront of innovative research in biomechanics.

Education

🎓 Educational Journey

PhD in Mechanics (2015-2022), Xi’an Jiaotong University
Thesis: “Theoretical Investigation into the Coupling Behaviour of Mechanoelectrical Tissue in Myocardial Fibrosis”
MA in Solid Mechanics (2013-2015), Xi’an Jiaotong University
BA in Structural Analysis of Engineering Structures (2009-2013), Xi’an Jiaotong University

Experience

💼 Professional Background

2023–Present: Assistant Researcher, Xi’an Jiaotong University, China
2022–2023: Assistant Researcher, China Aerodynamics Research and Development Centre
Collaboration with Siemens: Developed a facial beauty device integrating biomechanics with engineering, enabling product optimization.
Active participant in global cardiovascular disease research projects, presenting findings at international conferences.

Research Interests On Biology

🔬 Core Areas

Mechanics of Multi-Physical Field Coupling (Mechanics, Heat Transfer, Electric Fields)
Mechanical Behavior of Composite Materials
Quantitative Analysis and Experimental Mechanics Measurements

His research emphasizes myocardial fibrosis, mechanoelectrical coupling, and the interplay between matrix structures and electrokinetic functions.

Awards

🏆 Award Nomination

Dr. Liu is nominated for the Best Researcher Award for his innovative work in myocardial fibrosis and biomechanics, providing valuable insights for pathological understanding and targeted treatments.

Publications

📚 Key Research Contributions

“Modeling Fibroblast–Cardiomyocyte Interactions: Unveiling the Role of Ion Currents in Action Potential Modulation”
- Authors: Dong, Y., Liu, F.
- Year: 2024
- Citations: 0
“A new model of myofibroblast-cardiomyocyte interactions and their differences across species”
- Authors: Liu, F., Wu, H., Yang, X., Lu, T.J., Xu, F.
- Year: 2021
- Citations: 3
“Translation of a coated rigid spherical inclusion in an elastic matrix: Exact solution, and implications for mechanobiology”
- Authors: Chen, X., Li, M., Liu, S., Xu, F., Lu, T.J.
- Year: 2019
- Citations: 6
“Engineering mechanical-electrical cell microenvironment in myocardium using advanced biomaterials” (in Chinese)
- Authors: Xu, F., Zhang, X., Bao, X., Li, Y., Lu, T.
- Year: 2018
- Citations: 1
“The race to the nociceptor: mechanical versus temperature effects in thermal pain of dental neurons”
- Authors: Lin, M., Liu, F., Liu, S., Lu, T.J., Xu, F.
- Year: 2017
- Citations: 3
“Paracrine effects of adipose-derived stem cells on matrix stiffness-induced cardiac myofibroblast differentiation via angiotensin II type 1 receptor and smad7”
- Authors: Yong, K.W., Li, Y., Liu, F., Xu, F., Huang, G.
- Year: 2016
- Citations: 53
“Effect of viscoelasticity on skin pain sensation”
- Authors: Liu, F., Li, C., Liu, S., Lu, T., Xu, F.
- Year: 2015
- Citations: 11

Conclusion

✨ Vision and Impact
Dr. Fusheng Liu continues to push the boundaries of biomechanics with his innovative research and collaborative efforts. His dedication to advancing the understanding of myocardial fibrosis and tissue mechanics positions him as a leader in his field, inspiring future researchers and clinicians alike.

Christopher Reilly | Toxicology | Best Researcher Award

Published on 22/01/202522/01/2025 by Forensic Scientist Awards

Dr. Christopher Reilly | Toxicology | Best Researcher Award

Professor | University of Utah | United States

Dr. Christopher A. Reilly is a renowned pharmacologist and toxicologist at the University of Utah. As a professor and director of the Center for Human Toxicology, he has made significant contributions to understanding toxicological mechanisms, particularly involving TRP channels and environmental pollutants. With an extensive career in research, teaching, and mentoring, Dr. Reilly is a leader in the field, dedicated to advancing pharmacological sciences and improving public health.

Profile

Google Scholar

Scopus

Strengths for the Awards

Academic and Research Excellence:
Dr. Reilly has a distinguished academic background with a Ph.D. in Toxicology and over 25 years of research experience. His tenure as a professor and leadership roles, such as Director of the Center for Human Toxicology, underscore his expertise and impact in his field.
Extensive Publication and Research Funding:
Dr. Reilly has secured substantial research funding from prestigious institutions, including NIH, DOD, and NSF. His work covers critical topics such as air pollution, pharmacokinetics, TRP channels, and toxicology. His projects have garnered over $10 million in research funding, demonstrating his ability to lead impactful and high-value research.
Recognized Contributions:
He has received multiple honors, including the Gordon Research Conference Travel Awards and Colgate-Palmolive Post-Doctoral Fellowship, reflecting the significance of his contributions to toxicology. His publications have been featured in high-impact journals, with several being highlighted as “Manuscript Highlights” and “Cover Articles.”
Mentorship and Academic Service:
Dr. Reilly has mentored numerous students and fellows, several of whom have received significant awards and fellowships. He also contributes to academic governance, serving on multiple committees, including search committees, graduate councils, and retention and promotion committees.

Education 🎓

Dr. Reilly’s academic journey began at the University of Utah, where he earned a B.S. in Biology with emphases in Biochemistry, Molecular Biology, Ecology, and Evolution, and a minor in Chemistry (1994). He then pursued his Ph.D. in Toxicology at Utah State University (1999). Following his doctorate, he completed a prestigious postdoctoral fellowship in Pharmacology and Toxicology at the University of Utah, under the mentorship of Dr. Dennis J. Crouch and Dr. Garold S. Yost.

Experience 🏢

Dr. Reilly has built a distinguished career at the University of Utah, where he currently serves as Professor and Director of the Center for Human Toxicology. Since joining in 1999 as a postdoctoral fellow, he has held numerous roles, including Associate Director and Research Assistant Professor. His career highlights include mentoring in the Pediatric Clinical Pharmacology Program and conducting pioneering research in toxicology and pharmacology.

Research Interests Toxicology 🔬

Dr. Reilly’s research focuses on the toxicological mechanisms mediated by TRP channels, the impact of air pollution on health, and pharmacokinetics. His work delves into the interface of environmental toxicants and human physiology, with a particular emphasis on understanding molecular pathways for therapeutic interventions.

Awards and Honors 🏅

Dr. Reilly has received numerous accolades, including the 2001 Colgate-Palmolive Post-Doctoral Fellowship and the Society of Toxicology’s Domestic ToxScholar Visitor recognition in 2020-2021. He was also inducted as a Fellow of the Academy of Toxicological Sciences in 2023. His research publications have frequently been highlighted as “Featured Articles” or “Cover Articles,” reflecting their impact on the scientific community.

Publications 📚

Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors
Authors: CA Reilly, JL Taylor, DL Lanza, BA Carr, DJ Crouch, GS Yost
Year: 2003
Citations: 236
Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray products
Authors: CA Reilly, DJ Crouch, GS Yost
Year: 2001
Citations: 194
Peroxidase substrates stimulate the oxidation of hydralazine to metabolites which cause single-strand breaks in DNA
Authors: CA Reilly, SD Aust
Year: 1997
Citations: 189
Determination of capsaicin, dihydrocapsaicin, and nonivamide in self-defense weapons by liquid chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry
Authors: CA Reilly, DJ Crouch, GS Yost, AA Fatah
Year: 2001
Citations: 179
Human lung epithelial cells express a functional cold-sensing TRPM8 variant
Authors: AS Sabnis, M Shadid, GS Yost, CA Reilly
Year: 2008
Citations: 173
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
Authors: JD Phillips, HA Bergonia, CA Reilly, MR Franklin, JP Kushner
Year: 2007
Citations: 172
Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells
Authors: CA Reilly, WJ Ehlhardt, DA Jackson, P Kulanthaivel, AE Mutlib, RJ Espina, …
Year: 2003
Citations: 151
Measurement of lipid peroxidation
Authors: CA Reilly, SD Aust
Year: 1999
Citations: 147
Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes
Authors: CA Reilly, GS Yost
Year: 2006
Citations: 123
Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures
Authors: AS Sabnis, CA Reilly, JM Veranth, GS Yost
Year: 2008
Citations: 114

Conclusion ✨

Dr. Christopher A. Reilly exemplifies leadership and innovation in toxicology research, education, and mentorship. His dedication to unraveling the complexities of toxicological mechanisms and environmental health impacts has made a lasting impact in academia and beyond. As a mentor, researcher, and professor, Dr. Reilly continues to inspire the next generation of scientists and contribute significantly to public health initiatives.

Ming Xin | Toxicology | Best Researcher Award

Published on 18/01/202518/01/2025 by Forensic Scientist Awards

Mr. Ming Xin | Toxicology | Best Researcher Award

Pharmacist-in-charge | Liaocheng People’s Hospital | China

Ming Xin, currently serving as the Pharmacist-in-Charge at Liaocheng People’s Hospital, is a dedicated researcher with expertise in molecular pharmacology. His work focuses on understanding tumorigenesis, metastasis, and drug resistance, with the ultimate goal of discovering innovative anticancer therapies. Recognized for his contributions to science and healthcare, Ming Xin has played a pivotal role in advancing tumor research and supporting public health initiatives.

Profile

Scopus

Strengths for the Awards

Ming Xin demonstrates exceptional qualifications that align with the “Best Researcher Award” criteria:
- Impactful Research: His work on tumorigenesis, metastasis, and drug resistance addresses critical areas in oncology, making significant contributions to anticancer drug development.
- Publication Record: With 12 publications, including six in SCI-indexed journals, and a cumulative impact factor of 36.56, his research output is well-recognized within the scientific community.
- Research Funding: Successfully securing over 500,000 yuan in funding from competitive sources such as the Shandong Natural Science Foundation showcases his ability to lead impactful projects.
- Public Health Contributions: His participation in the Shandong Medical Team’s COVID-19 efforts, earning recognition from the Hainan Provincial Government, highlights his dedication beyond academic research.
- Recognized Achievements: Awards from Liaocheng People’s Hospital and the Hainan Provincial Government further validate his contributions to science and healthcare.

Education 🎓

Ming Xin possesses a strong academic foundation that underpins his research excellence. He has pursued advanced studies in pharmacology, equipping him with the knowledge and skills to explore the intricate mechanisms of cancer progression and resistance. His education has been complemented by continuous professional development, enabling him to lead impactful research projects.

Experience 🏥

With a distinguished career at Liaocheng People’s Hospital, Ming Xin has accumulated invaluable experience in both clinical and research settings. He has led multiple research projects funded by the Shandong Natural Science Foundation, contributing to advancements in anticancer drug development. Ming Xin also demonstrated his commitment to public health by participating in the Shandong Medical Team’s efforts during the COVID-19 pandemic, earning recognition from the Hainan Provincial Government.

Research Interest On Toxicology🔬

Ming Xin’s research centers on unraveling the molecular mechanisms behind tumor metastasis and multidrug resistance. He aims to identify biomarkers and develop novel therapeutic approaches to counter these challenges. His work is guided by a passion for innovation and a commitment to improving cancer treatment outcomes.

Awards 🏆

Honorary Certificate from the Hainan Provincial Government (2022) for contributions to epidemic control efforts.
Scientific Achievement Award from Liaocheng People’s Hospital (2023) on the 6th Chinese Physician Day.
Nominee for the Forensic Scientist Awards in the Best Researcher and Best Paper Award categories (2025).

Publications 📚

Ming Xin has published 12 impactful research papers, six of which are indexed in SCI journals. Below is a list of representative publications with hyperlinks, published years, and citation information:

“Targeting Tumor Metastasis Mechanisms”
- Published: 2022
- Journal: Drug Design, Development and Therapy
- Read here
“Exploring Novel Biomarkers for Multidrug Resistance”
- Published: 2022
- Journal: Frontiers in Pharmacology
- Read here
“Molecular Insights into Tumorigenesis”
- Published: 2022
- Journal: Cell Death & Disease
- Read here
“Herbal Compounds Against Drug Resistance”
- Published: 2022
- Journal: Pharmaceutical Biology
- Read here
“Innovative Approaches to Cancer Therapy”
- Published: 2016
- Journal: International Journal of Pharmaceutics
- Read here

Cited by over 80 articles in aggregate, these publications highlight his contribution to understanding cancer biology and therapeutics.

Conclusion 📝

Ming Xin is a distinguished researcher and healthcare professional committed to advancing the fight against cancer. His work bridges the gap between molecular pharmacology and therapeutic applications, making significant strides in understanding and overcoming challenges in cancer treatment. Through his dedication, Ming Xin continues to inspire innovation and contribute to the global scientific community.